Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**MT-ND2 pseudogene 5 (MTND2P5)** is classified as a mitochondrial pseudogene, meaning it is a non-functional genomic DNA sequence similar to the functional gene MT-ND2, which encodes a core subunit of mitochondrial Complex I. Unlike the canonical MT-ND2 gene, MTND2P5 does not produce a protein product and has no established biological function, disease association, or role as a drug target. It is catalogued as a pseudogene in genomic nomenclature resources[6][4]. This entry is not considered a therapeutic target, nor is there evidence of its involvement as a biomarker, disease modifier, or interaction partner for any drugs. It should not be confused with the functional **MT-ND2 gene** (mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2), which plays well-characterized roles in mitochondrial electron transport and is implicated in mitochondrial diseases[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND2 pseudogene 5 (MTND2P5).